Table 4.
Treatments of patients pre- and post-clinical practice guidelines implementation.
| Diagnostic testing | Pre-CPG | Post-CPG | p |
|---|---|---|---|
| Therapeutic intervention | Pre-CPG | Post-CPG | p |
| Nasal suctioning | 9 (10.2) | 83 (91.2) | <0.001* |
| Scheduled salbutamol | 44(50) | 29 (31.9) | 0.01* |
| Salbutamol trial | 24 (27.3) | 21 (23.1) | 0.52 |
| Nebulized hypertonic saline | 39 (44.3) | 8 (8.8) | <0.001* |
| Inhaled corticosteroid | 3(3.4) | 3(3.3) | 0.97 |
| Systemic steroids | 8 (9.1) | 5 (5.5) | 0.35 |
| Antibiotics | 52 (59.1) | 44 (48.4) | 0.15 |
| Inappropriate antibiotic use (no indication) | 31 (35.2) | 15 (16.5) | 0.004* |
| Chest physiotherapy | 7 (8.0) | 8 (8.8) | 0.840 |
Data presented as number and (%)
*statistically significant at p<0.05.